Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 10 | 2 | 12 |
Phenylethanolamine N-methyltransferase | 0 | 3 | 0 | 3 |
Cytochrome P450 2A6 | 0 | 2 | 0 | 2 |
Substance-P receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 11 | 2 | 13 |
5-hydroxytryptamine receptor 1A | 0 | 11 | 2 | 13 |
Cytochrome P450 2A5 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 11 | 1 | 12 |
5-hydroxytryptamine receptor 1B | 0 | 8 | 2 | 10 |
5-hydroxytryptamine receptor 1D | 0 | 4 | 2 | 6 |
5-hydroxytryptamine receptor 1F | 0 | 4 | 2 | 6 |
5-hydroxytryptamine receptor 2B | 0 | 9 | 3 | 12 |
5-hydroxytryptamine receptor 6 | 0 | 0 | 2 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 5 | 2 | 7 |
5-hydroxytryptamine receptor 5A | 0 | 0 | 2 | 2 |
5-hydroxytryptamine receptor 5B | 0 | 0 | 2 | 2 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 2 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 4 | 0 | 0 | 2 | 2 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 2 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 5 | 2 | 7 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 5 | 0 | 0 | 5 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 5 | 0 | 0 | 5 |
5-hydroxytryptamine receptor 3E | 0 | 4 | 0 | 4 |
acetylcholinesterase | 7 | 0 | 0 | 7 |
hypoxia-inducible factor 1 alpha subunit | 5 | 0 | 0 | 5 |
RAR-related orphan receptor gamma | 7 | 0 | 0 | 7 |
SMAD family member 2 | 3 | 0 | 0 | 3 |
Fumarate hydratase | 6 | 0 | 0 | 6 |
USP1 protein, partial | 4 | 0 | 0 | 4 |
PPM1D protein | 3 | 0 | 0 | 3 |
SMAD family member 3 | 3 | 0 | 0 | 3 |
TDP1 protein | 12 | 0 | 0 | 12 |
GLI family zinc finger 3 | 11 | 0 | 0 | 11 |
Microtubule-associated protein tau | 6 | 0 | 0 | 6 |
AR protein | 13 | 0 | 0 | 13 |
estrogen receptor 2 (ER beta) | 6 | 0 | 0 | 6 |
nuclear receptor subfamily 1, group I, member 3 | 11 | 0 | 0 | 11 |
progesterone receptor | 7 | 0 | 0 | 7 |
EWS/FLI fusion protein | 7 | 0 | 0 | 7 |
glucocorticoid receptor [Homo sapiens] | 12 | 0 | 0 | 12 |
retinoic acid nuclear receptor alpha variant 1 | 12 | 0 | 0 | 12 |
retinoid X nuclear receptor alpha | 9 | 0 | 0 | 9 |
estrogen-related nuclear receptor alpha | 13 | 0 | 0 | 13 |
farnesoid X nuclear receptor | 5 | 0 | 0 | 5 |
pregnane X nuclear receptor | 7 | 0 | 0 | 7 |
estrogen nuclear receptor alpha | 13 | 0 | 0 | 13 |
G | 4 | 0 | 0 | 4 |
cytochrome P450 2D6 | 13 | 0 | 0 | 13 |
polyprotein | 6 | 0 | 0 | 6 |
67.9K protein | 3 | 0 | 0 | 3 |
peroxisome proliferator-activated receptor delta | 10 | 0 | 0 | 10 |
peroxisome proliferator activated receptor gamma | 5 | 0 | 0 | 5 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 6 | 0 | 0 | 6 |
euchromatic histone-lysine N-methyltransferase 2 | 9 | 0 | 0 | 9 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 6 | 0 | 0 | 6 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 9 | 0 | 0 | 9 |
lysosomal alpha-glucosidase preproprotein | 3 | 0 | 0 | 3 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
potassium voltage-gated channel subfamily H member 2 isoform d | 11 | 0 | 0 | 11 |
transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform 2 | 10 | 0 | 0 | 10 |
heat shock protein beta-1 | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 10 | 0 | 0 | 10 |
nuclear receptor ROR-gamma isoform 1 | 6 | 0 | 0 | 6 |
geminin | 14 | 0 | 0 | 14 |
peripheral myelin protein 22 | 9 | 0 | 0 | 9 |
histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 3 | 0 | 3 |
ATP-binding cassette sub-family C member 3 | 0 | 8 | 0 | 8 |
Multidrug resistance-associated protein 4 | 0 | 8 | 0 | 8 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 6 | 0 | 0 | 6 |
5-hydroxytryptamine receptor 3B | 0 | 4 | 0 | 4 |
Bile salt export pump | 0 | 13 | 0 | 13 |
Interferon beta | 6 | 0 | 0 | 6 |
HLA class I histocompatibility antigen, B alpha chain | 4 | 0 | 0 | 4 |
Cellular tumor antigen p53 | 9 | 0 | 0 | 9 |
ATP-dependent translocase ABCB1 | 0 | 7 | 0 | 11 |
Cytochrome P450 3A4 | 0 | 8 | 0 | 10 |
5-hydroxytryptamine receptor 1A | 0 | 10 | 4 | 14 |
Neuronal acetylcholine receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-2 | 2 | 0 | 0 | 2 |
D(2) dopamine receptor | 0 | 19 | 6 | 31 |
Alpha-1B adrenergic receptor | 0 | 10 | 1 | 11 |
Alpha-2C adrenergic receptor | 0 | 15 | 0 | 15 |
D | 0 | 11 | 0 | 11 |
Glutamate receptor 2 | 6 | 0 | 0 | 6 |
Muscarinic acetylcholine receptor M3 | 0 | 12 | 1 | 13 |
D(1A) dopamine receptor | 0 | 13 | 2 | 17 |
D(4) dopamine receptor | 0 | 13 | 3 | 20 |
D(1B) dopamine receptor | 0 | 6 | 1 | 9 |
Alpha-1D adrenergic receptor | 0 | 8 | 1 | 9 |
Alpha-1D adrenergic receptor | 0 | 13 | 0 | 13 |
5-hydroxytryptamine receptor 2A | 0 | 16 | 2 | 21 |
5-hydroxytryptamine receptor 2C | 0 | 15 | 1 | 16 |
D(4) dopamine receptor | 0 | 8 | 0 | 8 |
Histamine H1 receptor | 0 | 4 | 0 | 4 |
Sodium-dependent serotonin transporter | 0 | 19 | 2 | 21 |
5-hydroxytryptamine receptor 7 | 0 | 7 | 0 | 7 |
Alpha-1A adrenergic receptor | 0 | 10 | 0 | 10 |
Histamine H1 receptor | 0 | 13 | 4 | 20 |
Alpha-1B adrenergic receptor | 0 | 7 | 0 | 7 |
D(3) dopamine receptor | 0 | 15 | 5 | 25 |
5-hydroxytryptamine receptor 2B | 0 | 14 | 1 | 15 |
Alpha-1A adrenergic receptor | 0 | 10 | 1 | 11 |
5-hydroxytryptamine receptor 3A | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 6 | 0 | 12 | 0 | 13 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 6 | 0 | 6 |
Spike glycoprotein | 9 | 1 | 1 | 11 |
D(2) dopamine receptor | 0 | 15 | 1 | 16 |
Inositol monophosphatase 1 | 5 | 0 | 0 | 5 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 17 | 0 | 17 |
5-hydroxytryptamine receptor 3D | 0 | 4 | 0 | 4 |
Multidrug and toxin extrusion protein 2 | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 3C | 0 | 4 | 0 | 4 |
Inositol hexakisphosphate kinase 1 | 4 | 0 | 0 | 4 |
Canalicular multispecific organic anion transporter 1 | 0 | 8 | 0 | 8 |
Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
Histamine H3 receptor | 0 | 4 | 0 | 4 |
cytochrome P450 2C9, partial | 4 | 0 | 0 | 4 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 5 | 0 | 0 | 5 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
Chain A, 2-oxoglutarate Oxygenase | 4 | 0 | 0 | 4 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
thioredoxin reductase | 6 | 0 | 0 | 6 |
GLS protein | 5 | 0 | 0 | 5 |
aldehyde dehydrogenase 1 family, member A1 | 4 | 0 | 0 | 4 |
thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 10 | 0 | 0 | 10 |
glucocerebrosidase | 5 | 0 | 0 | 5 |
Rac1 protein | 0 | 0 | 1 | 1 |
IDH1 | 5 | 0 | 0 | 5 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
Bloom syndrome protein isoform 1 | 4 | 0 | 0 | 4 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
DNA polymerase iota isoform a (long) | 4 | 0 | 0 | 4 |
DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
muscarinic acetylcholine receptor M1 | 7 | 0 | 0 | 7 |
lethal factor (plasmid) | 5 | 0 | 0 | 5 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 5 | 0 | 5 |
Carbonic anhydrase 2 | 0 | 5 | 0 | 5 |
Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
Integrin beta-3 | 2 | 1 | 0 | 3 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 2 | 1 | 0 | 3 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Adenosine receptor A1 | 0 | 4 | 0 | 4 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 4 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 5 | 2 | 0 | 7 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 8 | 1 | 9 |
glp-1 receptor, partial | 5 | 0 | 0 | 5 |
Sodium-dependent noradrenaline transporter | 0 | 16 | 2 | 18 |
Chain A, Cruzipain | 2 | 0 | 0 | 2 |
caspase 7, apoptosis-related cysteine protease | 5 | 0 | 0 | 5 |
caspase-3 | 5 | 0 | 0 | 5 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 5 | 0 | 0 | 5 |
Caspase-7 | 3 | 0 | 0 | 3 |
vitamin D3 receptor isoform VDRA | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
caspase-3 | 3 | 0 | 0 | 3 |
Solute carrier organic anion transporter family member 2B1 | 0 | 0 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
Insulin receptor | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Histone deacetylase 1 | 0 | 3 | 0 | 3 |
Histone deacetylase 2 | 0 | 3 | 0 | 3 |
Solute carrier organic anion transporter family member 1B3 | 0 | 0 | 0 | 1 |
Histone deacetylase 6 | 0 | 3 | 0 | 3 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 2 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Chain A, serum paraoxonase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
Neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 6 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 2 |
Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 9 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 2 |
Luciferase | 2 | 0 | 0 | 2 |
ATAD5 protein, partial | 4 | 0 | 0 | 4 |
NFKB1 protein, partial | 4 | 0 | 0 | 4 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 4 | 0 | 0 | 4 |
Adenylate cyclase type 1 | 0 | 2 | 0 | 2 |
Histone H2A.x | 1 | 0 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 6 | 0 | 0 | 6 |
peripheral myelin protein 22 isoform 1 | 5 | 0 | 0 | 5 |
cytochrome P450 2C19 precursor | 4 | 0 | 0 | 4 |
cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
D(1A) dopamine receptor | 5 | 0 | 0 | 5 |
chromobox protein homolog 1 | 5 | 0 | 0 | 5 |
DNA polymerase beta | 2 | 0 | 0 | 2 |
mitogen-activated protein kinase 1 | 7 | 0 | 0 | 7 |
atrial natriuretic peptide receptor 2 precursor | 2 | 0 | 0 | 2 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
survival motor neuron protein isoform d | 4 | 0 | 0 | 4 |
cytochrome P450 3A4 isoform 1 | 5 | 0 | 0 | 5 |
M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
transient receptor potential cation channel subfamily V member 1 | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 8 | 0 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit pi | 5 | 1 | 0 | 6 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 4 | 0 | 4 |
Bile salt export pump | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 4 | 0 | 12 | 0 | 12 |
Albumin | 0 | 0 | 3 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 9 | 0 | 9 |
Muscarinic acetylcholine receptor M2 | 0 | 11 | 1 | 12 |
Muscarinic acetylcholine receptor M4 | 0 | 11 | 1 | 12 |
Muscarinic acetylcholine receptor M1 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M3 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M4 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M5 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M5 | 0 | 10 | 0 | 10 |
Alpha-2A adrenergic receptor | 0 | 14 | 0 | 14 |
Calmodulin-1 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 4 | 0 | 4 |
Cytochrome P450 2D6 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M2 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M1 | 0 | 12 | 2 | 14 |
Cytochrome P450 2C9 | 0 | 4 | 1 | 6 |
Angiotensin-converting enzyme | 0 | 10 | 0 | 10 |
Gamma-aminobutyric acid receptor subunit beta-1 | 5 | 1 | 0 | 6 |
Alpha-2B adrenergic receptor | 0 | 14 | 0 | 14 |
Beta-1 adrenergic receptor | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit delta | 5 | 1 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 5 | 1 | 0 | 6 |
D(3) dopamine receptor | 0 | 10 | 1 | 11 |
Alpha-2B adrenergic receptor | 0 | 6 | 1 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 5 | 1 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 5 | 1 | 0 | 6 |
D(2) dopamine receptor | 0 | 5 | 0 | 5 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 3 | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 6 | 1 | 7 |
UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 3 |
Alpha-2A adrenergic receptor | 0 | 6 | 1 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 5 | 1 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 5 | 1 | 0 | 6 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 0 | 9 | 2 | 11 |
D(1B) dopamine receptor | 0 | 6 | 0 | 6 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
Adenylate cyclase type 2 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 4 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 5 | 1 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 5 | 1 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 5 | 1 | 0 | 6 |
Histamine H1 receptor | 0 | 4 | 0 | 4 |
Sodium-dependent serotonin transporter | 0 | 5 | 1 | 6 |
Cytochrome P450 2C19 | 0 | 2 | 0 | 3 |
5-hydroxytryptamine receptor 2C | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2A | 0 | 3 | 0 | 3 |
Adenylate cyclase type 8 | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 4 | 0 | 0 | 5 |
5-hydroxytryptamine receptor 5A | 0 | 2 | 0 | 2 |
Cytochrome P450 2J2 | 0 | 3 | 0 | 4 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
Gastrin/cholecystokinin type B receptor | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Calmodulin | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 5 | 1 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit beta-2 | 5 | 1 | 0 | 6 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 4 | 0 | 4 |
Sodium-dependent dopamine transporter | 0 | 12 | 2 | 14 |
5-hydroxytryptamine receptor 2B | 0 | 3 | 0 | 3 |
Adenylate cyclase type 6 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 5 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 4 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 4 |
Transporter | 0 | 6 | 0 | 6 |
Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 9 | 0 | 9 |
Adenylyl cyclase 7 | 0 | 2 | 0 | 2 |
GABA theta subunit | 5 | 1 | 0 | 6 |
D | 0 | 4 | 0 | 4 |
ATPase family AAA domain-containing protein 5 | 5 | 0 | 0 | 5 |
Ataxin-2 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit epsilon | 5 | 1 | 0 | 6 |
Histamine H4 receptor | 0 | 3 | 2 | 5 |
Transporter | 0 | 6 | 0 | 6 |
aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
endonuclease IV | 2 | 0 | 0 | 2 |
nonstructural protein 1 | 3 | 0 | 0 | 3 |
phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
Thrombopoietin | 3 | 0 | 0 | 3 |
NADPH oxidase 1 | 0 | 1 | 0 | 1 |
regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
arylsulfatase A | 5 | 0 | 0 | 5 |
Snq2p | 0 | 0 | 0 | 1 |
Spike glycoprotein | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
serine/threonine-protein kinase mTOR isoform 1 | 4 | 0 | 0 | 4 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
Transmembrane protease serine 2 | 0 | 1 | 1 | 2 |
Potassium channel subfamily K member 2 | 0 | 3 | 2 | 5 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Procathepsin L | 0 | 1 | 1 | 2 |
Replicase polyprotein 1a | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Beta-3 adrenergic receptor | 0 | 3 | 0 | 3 |
Androgen receptor | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 2 | 0 | 2 |
Trypanothione reductase | 0 | 2 | 0 | 2 |
Melanocortin receptor 5 | 0 | 4 | 0 | 4 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
Mu-type opioid receptor | 0 | 5 | 1 | 6 |
Delta-type opioid receptor | 0 | 4 | 0 | 4 |
Kappa-type opioid receptor | 0 | 3 | 0 | 3 |
D(1A) dopamine receptor | 4 | 1 | 0 | 5 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
Disintegrin and metalloproteinase domain-containing protein 17 | 3 | 0 | 0 | 3 |
Angiotensin-converting enzyme 2 | 0 | 1 | 1 | 2 |
ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
Cocaine esterase | 0 | 2 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 3 |
Major prion protein | 0 | 0 | 1 | 1 |
Vitamin D-binding protein | 0 | 1 | 0 | 1 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 4 |
C-8 sterol isomerase | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 2 | 0 | 2 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
Sodium channel protein type 5 subunit alpha | 0 | 3 | 0 | 3 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 2 | 0 | 2 |
Zinc finger protein 664 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
Protease | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Sodium channel protein type 11 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 8 subunit alpha | 0 | 2 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 2 | 0 | 2 |
Translocator protein | 0 | 1 | 0 | 1 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
Polyphenol oxidase 2 | 0 | 2 | 0 | 3 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Cholesteryl ester transfer protein | 0 | 1 | 0 | 1 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 3 | 0 | 0 | 1 | 1 |
Nicotinamidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 0 | 1 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 2 | 1 | 3 |
D-aspartate oxidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 1 | 1 | 2 |
FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
pregnane X receptor | 2 | 0 | 0 | 2 |
GALC protein | 1 | 0 | 0 | 1 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
DNA polymerase III, partial | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
XBP1 | 0 | 1 | 0 | 1 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
DNA damage-inducible transcript 3 protein | 0 | 1 | 0 | 1 |
urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
plasminogen precursor | 2 | 0 | 0 | 2 |
urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
Voltage-dependent T-type calcium channel subunit alpha-1G | 0 | 0 | 1 | 1 |
Ubiquitin carboxyl-terminal hydrolase 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Glycine receptor subunit alpha-1 | 0 | 0 | 2 | 2 |
WD repeat-containing protein 48 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1E | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 0 | 0 | 1 |
Smad3 | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 0 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
Albumin | 0 | 1 | 0 | 1 |
Polymerase acidic protein | 0 | 0 | 1 | 1 |
Stromelysin-1 | 0 | 0 | 1 | 1 |
Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 3 |
Estrogen receptor | 0 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Envelope glycoprotein | 0 | 0 | 1 | 1 |
Histone deacetylase 3 | 0 | 2 | 0 | 2 |
Tissue factor | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
Histone deacetylase 7 | 0 | 2 | 0 | 2 |
Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
Histone deacetylase 11 | 0 | 2 | 0 | 2 |
Histone deacetylase 8 | 0 | 2 | 0 | 2 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
Histone deacetylase 9 | 0 | 2 | 0 | 2 |
Histone deacetylase 5 | 0 | 2 | 0 | 2 |
Aspartate aminotransferase, cytoplasmic | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |